|

MB-CART20.1 Clinical Trials

1 actively recruiting trial

Also known as: Anti-CD20 CAR T cells, CD20-targeting CAR T cells

Top Sponsors

  • Miltenyi Biomedicine GmbH1

Indications

  • Chronic Lymphatic Leukemia1
  • Childhood Non-Hodgkin Lymphoma1
  • Acute Lymphatic Leukemia1
  • Melanoma Stage III1
  • Melanoma Stage IV1

Other1 trial

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.